PET Drug Proposed Rule Clears OMB
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's proposed rule on current good manufacturing practices for positron emission tomography drugs is headed for publication in the Federal Register following clearance by the Office of Management & Budget Aug. 30